{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:32:17Z","timestamp":1790821937393,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Eurofarma Laborat\u00f3rios S.A."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s42358-018-0041-9","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T07:02:52Z","timestamp":1543993372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis"],"prefix":"10.1186","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1223-4459","authenticated-orcid":false,"given":"Andrea Barranjard Vannucci","family":"Lomonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alexandre","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"de Castro Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marise Lazaretti","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"issue":"1","key":"41_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008;58(1):26\u201335.","journal-title":"Part II Arthritis Rheum"},{"issue":"9859","key":"41_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163\u201396.","journal-title":"Lancet"},{"key":"41_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2174\/1874325001307010619","volume":"7","author":"J Farr Ii","year":"2013","unstructured":"Farr Ii J, Miller LE, Block JE. Quality of life in patients with knee osteoarthritis: a commentary on nonsurgical and surgical treatments. Open Orthop J. 2013;7:619\u201323.","journal-title":"Open Orthop J"},{"issue":"8","key":"41_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9","volume":"41","author":"DT Felson","year":"1998","unstructured":"Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343\u201355.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"41_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/art.24021","volume":"59","author":"L Murphy","year":"2008","unstructured":"Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008;59(9):1207\u201313.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"41_CR6","first-page":"371","volume":"42","author":"IB Coimbra","year":"2002","unstructured":"Coimbra IB, Pastor EH, Greve JMD, Puccinelli MLC, Fuller R, Cavalcanti FS, Maciel FMB, Honda E. Consenso brasileiro para o tratamento da osteoartrite (artrose). Rev Bras Reumatol. 2002;42(6):371\u20134.","journal-title":"Rev Bras Reumatol"},{"issue":"1\u20132","key":"41_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.20452\/pamw.3271","volume":"126","author":"W Mosleh","year":"2016","unstructured":"Mosleh W, Farkouh ME. Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti-inflammatory drugs. Pol Arch Med Wewn. 2016;126(1\u20132):68\u201375.","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"41_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.semarthrit.2013.11.012","volume":"43","author":"AE Nelson","year":"2014","unstructured":"Nelson AE, Allen KD, Golightly YM, Goode P, Jordan JM. A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum. 2014;43(6):701\u201312.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"41_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1211\/jpp.61.10.0002","volume":"61","author":"N Volpi","year":"2009","unstructured":"Volpi N. Quality of different chondroitin sulfate preparations in relation to their therapeutic activity. J Pharm Pharmacol. 2009;61(10):1271\u201380.","journal-title":"J Pharm Pharmacol"},{"issue":"11","key":"41_CR10","first-page":"2407","volume":"29","author":"AS Russell","year":"2002","unstructured":"Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol. 2002;29(11):2407\u20139.","journal-title":"J Rheumatol"},{"issue":"5","key":"41_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1185\/03007995.2015.1027183","volume":"31","author":"JY Reginster","year":"2015","unstructured":"Reginster JY, Cooper C, Hochberg M, Pelletier JP, Rizzoli R, Kanis J, Abadie E, Maheu E, Brandi ML, Devogelaer JP, Branco J, Herrero-Beaumont G, D\u2019Hooghe P, Bruy\u00e8re O. Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Curr Med Res Opin. 2015;31(5):1041\u20135.","journal-title":"Curr Med Res Opin"},{"key":"41_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip and knee. Arthritis Care Res (Hoboken). 2012;64:465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"41_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K, Lohmander S, Rannou F, Roos EM, Underwood M. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363\u201388.","journal-title":"Osteoarthr Cartil"},{"issue":"4 Suppl","key":"41_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.semarthrit.2015.11.010","volume":"45","author":"O Bruyere","year":"2016","unstructured":"Bruyere O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, Martel-Pelletier J, Reginster JY. A consensus statement on the European Society for Clinical and Economic Aspects of osteoporosis and osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis \u2013 from evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3\u201311.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"41_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/joca.1999.0308","volume":"8","author":"A Das Jr","year":"2000","unstructured":"Das A Jr, Hammad TA. Efficacy of a combination of FCHG49\u2122 glucosamine hydrochloride, TRH122\u2122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthr Cartil. 2000;8(5):343\u201350.","journal-title":"Osteoarthr Cartil"},{"key":"41_CR16","first-page":"73","volume-title":"Practical statistics for medical research","author":"D Altman","year":"1991","unstructured":"Altman D. Practical statistics for medical research. Londres: Chapman & Hall\/ CRC; 1991. p. 73\u20137."},{"key":"41_CR17","unstructured":"Kellner, S. R. O. Estat\u00edstica sem mist\u00e9rios. Volume I, segunda edi\u00e7\u00e3o. Editora Vozes, p. 433\u2013434."},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"C4675","DOI":"10.1136\/bmj.c4675","volume":"341","author":"S Wandel","year":"2010","unstructured":"Wandel S, J\u00fcni P, Tendal B, N\u00fcesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoartrhtis of hip or knee: network meta-analysis. BMJ. 2010;341:C4675.","journal-title":"BMJ"},{"key":"41_CR19","doi-asserted-by":"publisher","first-page":"16827","DOI":"10.1038\/srep16827","volume":"5","author":"C Zeng","year":"2015","unstructured":"Zeng C, Wei J, Li H, Wang YL, Xie DX, Yang T, Gao SG, Li YS, Luo W, Lei GH. Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of knee. Sci Rep. 2015;5:16827.","journal-title":"Sci Rep"},{"issue":"1","key":"41_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2014-206792","volume":"75","author":"MC Hochberg","year":"2016","unstructured":"Hochberg MC, Martel-Pelletier J, Monfort J, M\u00f6ller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Dom\u00e9nech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"41_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.joca.2007.06.011","volume":"16","author":"O Bruyere","year":"2008","unstructured":"Bruyere O, Pavelka K, Rovati LC, Gatterov\u00e1 J, Giacovelli G, Olejarov\u00e1 M, Deroisy R, Reginster JY. Total joint replacement after glucosamine sulfate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from previous 3-year, randomised, placebo-controlles trials. Osteoarthr Cartil. 2008;16(2):254\u201360.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"41_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.joca.2009.07.005","volume":"18","author":"JA Block","year":"2010","unstructured":"Block JA, Oegema TR, Sandy JD, Plaas A. The effects of oral glucosamine on joint health: is a change in research approach needed? Osteoarthr Cartil. 2010;18(1):5\u201311.","journal-title":"Osteoarthr Cartil"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-018-0041-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:16:09Z","timestamp":1775294169000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-018-0041-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1186\/s42358-018-0041-9","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted following international and local ethical standards and regulations, and was approved by the Independent Ethics Committee from each participating institution before its beginning, with the following sites and their respective RECs: Hospital Heli\u00f3polis Research Ethics Committee (Centro Paulista de Investiga\u00e7\u00f5es Cl\u00ednicas Ltda.), Research Ethics Committee \u2013 UNICAMP (Instituto de Pesquisa Cl\u00ednica e Assist\u00eancia Medica de Campinas), Instituto do C\u00e2ncer Dr. Arnaldo de Vieira de Carvalho Research Ethics Committee (Cl\u00ednica Perdizes) and Faculdade de Medicina do ABC Research Ethics Committee (Instituto de Medicina Avan\u00e7ada).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Andrea B. V. Lomonte was a medical-scientific advisor and was paid by Eurofarma Laborat\u00f3rios S.A. to write the scientific article. Dr. Jos\u00e9 Alexandre Mendon\u00e7a and Dr. Gilberto C. Brand\u00e3o were investigators in that study and were paid by Eurofarma Laborat\u00f3rios S.A. to conduct the clinical trial. Dr. Marise L. Castro was paid by Eurofarma Laborat\u00f3rios S.A. to conduct the trial and she participates in clinical trials sponsored by Laborat\u00f3rios Ach\u00e9, Sanofi, Eurofarma, Eli Lilly and Amgen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"41"}}